Thrombosis in newborn infants

Area of Science:

• Pediatrics
• Hematology
• Neonatology

Background:

• Neonatal thrombosis incidence surpasses other pediatric stages.
• Immature hemostatic system, risk factors, and vascular catheter use contribute to thrombosis.
• Venous thromboses (limbs, renal veins, right atrium) are more common than arterial.
• Stroke can result from arterial or venous cerebral system occlusion.

Purpose of the Study:

• To review the incidence, causes, and management of thrombosis in newborn infants.
• To highlight severe thrombotic conditions like purpura fulminans and their specific treatments.
• To outline current therapeutic strategies for neonatal thrombotic events.

Main Methods:

• Literature review of neonatal thrombosis.
• Analysis of risk factors and common thrombotic sites.
• Summary of treatment modalities including antithrombotic, replacement, and thrombolytic therapies.

Main Results:

• Neonatal hemostatic system immaturity and catheter use are key factors.
• Venous thromboses are more prevalent than arterial.
• Purpura fulminans is a critical condition linked to protein deficiencies.
• Heparins are primary antithrombotic agents; thrombolytics are reserved for severe cases.

Conclusions:

• Prompt diagnosis and management are crucial for neonatal thrombosis.
• Antithrombotic therapy with heparins is standard for most events.
• Specific treatments are vital for severe conditions like purpura fulminans and life-threatening thrombosis.